<SEC-DOCUMENT>0001447028-25-000059-index.html : 20250306
<SEC-HEADER>0001447028-25-000059.hdr.sgml : 20250306
<ACCEPTANCE-DATETIME>20250306160701
ACCESSION NUMBER:		0001447028-25-000059
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250224
FILED AS OF DATE:		20250306
DATE AS OF CHANGE:		20250306

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Gline Matthew
		CENTRAL INDEX KEY:			0001750094
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34949
		FILM NUMBER:		25715237

	MAIL ADDRESS:	
		STREET 1:		ROIVANT SCIENCES, INC.
		STREET 2:		151 W. 42ND ST., 15TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arbutus Biopharma Corp
		CENTRAL INDEX KEY:			0001447028
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				980597776
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		701 VETERANS CIRCLE
		CITY:			WARMINSTER
		STATE:			PA
		ZIP:			18974
		BUSINESS PHONE:		604-419-3200

	MAIL ADDRESS:	
		STREET 1:		701 VETERANS CIRCLE
		CITY:			WARMINSTER
		STATE:			PA
		ZIP:			18974

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TEKMIRA PHARMACEUTICALS Corp
		DATE OF NAME CHANGE:	20110607

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TEKMIRA PHARMACEUTICALS CORP
		DATE OF NAME CHANGE:	20081003
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>wk-form3_1741295212.xml
<DESCRIPTION>FORM 3
<TEXT>
Document 1 - file: wk-form3_1741295212.html

Document 1 - RAW XML: wk-form3_1741295212.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>abus-secfilingspowerofat.htm
<DESCRIPTION>EX-24
<TEXT>
Document 2 - file: abus-secfilingspowerofat.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>abus-secfilingspowerofat001.jpg
<TEXT>
Document 3 - file: abus-secfilingspowerofat001.jpg

</DOCUMENT>
</SEC-DOCUMENT>